Literature DB >> 10679760

Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice.

A Bylund1, J X Zhang, A Bergh, J E Damber, A Widmark, A Johansson, H Adlercreutz, P Aman, M J Shepherd, G Hallmans.   

Abstract

BACKGROUND: In this study, we investigated whether dietary intervention could inhibit tumor growth of an androgen-sensitive human prostatic cancer.
METHODS: LNCaP cells were transplanted subcutaneously in nude-mice. The animals were then put on different diets and tumor take, tumor growth and prostate specific antigen (PSA) secretion were studied during 9 weeks.
RESULTS: Palpable tumors developed in 75% of the tumor-cell injected sites in animals fed a control diet (corn starch, sucrose, etc.) whereas, for animals given rye bran (RB), ethyl acetate extraction from rye bran supplemented cellulose based diets (CCEE), palpable tumors were seen in only 30% and for soy protein based diets (SCC) 50% of the transplantation sites, respectively. The tumors that grew to palpable size in the rye (RB) and soy (SCC) groups were smaller and secreted less PSA than those in the control group. In the rye and soy groups tumor cell apoptosis was increased, but cell proliferation was unaffected. Addition of fat to the rye diet reduced its effect on prostate cancer growth.
CONCLUSIONS: Factors in rye bran and soy protein may inhibit prostate cancer growth. The effect is more apparent for rye than for soy. Further studies are needed to identify the effective substances and to explore the mechanism of action. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679760     DOI: 10.1002/(sici)1097-0045(20000301)42:4<304::aid-pros8>3.0.co;2-z

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

1.  Opportunities for prevention of prostate cancer: genetics, chemoprevention, and dietary intervention.

Authors:  Eric A Klein
Journal:  Rev Urol       Date:  2002

2.  Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey.

Authors:  Michael K Reger; Terrell W Zollinger; Ziyue Liu; Josette Jones; Jianjun Zhang
Journal:  Eur J Nutr       Date:  2015-05-06       Impact factor: 5.614

3.  Soybean peptide fractions inhibit human blood, breast and prostate cancer cell proliferation.

Authors:  Srinivas J Rayaprolu; Navam S Hettiarachchy; Ronny Horax; Geetha Kumar Phillips; Mahadevan Mahendran; Pengyin Chen
Journal:  J Food Sci Technol       Date:  2017-01-13       Impact factor: 2.701

4.  Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey.

Authors:  Esther Walser-Domjan; Aline Richard; Monika Eichholzer; Elizabeth A Platz; Jakob Linseisen; Sabine Rohrmann
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

Review 5.  Functional foods and their role in cancer prevention and health promotion: a comprehensive review.

Authors:  Mohammad Aghajanpour; Mohamad Reza Nazer; Zia Obeidavi; Mohsen Akbari; Parya Ezati; Nasroallah Moradi Kor
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

6.  Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer.

Authors:  A K Eriksen; C Kyrø; N Nørskov; A K Bolvig; J Christensen; A Tjønneland; K Overvad; R Landberg; A Olsen
Journal:  Eur J Clin Nutr       Date:  2017-04-05       Impact factor: 4.016

7.  Rye bread consumption in early life and reduced risk of advanced prostate cancer.

Authors:  Johanna E Torfadottir; Unnur A Valdimarsdottir; Lorelei Mucci; Meir Stampfer; Julie L Kasperzyk; Katja Fall; Laufey Tryggvadottir; Thor Aspelund; Orn Olafsson; Tamara B Harris; Eirikur Jonsson; Hrafn Tulinius; Hans-Olov Adami; Vilmundur Gudnason; Laufey Steingrimsdottir
Journal:  Cancer Causes Control       Date:  2012-04-25       Impact factor: 2.506

8.  Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT.

Authors:  Wellington K Hsu; Mandeep S Virk; Brian T Feeley; David B Stout; Arion F Chatziioannou; Jay R Lieberman
Journal:  J Nucl Med       Date:  2008-02-20       Impact factor: 10.057

Review 9.  [A critical assessment of phytotherapy for prostate cancer].

Authors:  F G E Perabo; E C von Löw; R Siener; J Ellinger; S C Müller; P J Bastian
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

10.  Present status and perspectives on the use of alkylresorcinols as biomarkers of wholegrain wheat and rye intake.

Authors:  Alastair B Ross
Journal:  J Nutr Metab       Date:  2012-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.